[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100536194":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":30,"responsibleParty":57,"collaborators":19,"id":60,"slug":19,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":19,"maxAge":19,"enrollmentInfo":67,"targetDuration":19,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":79,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study group","EXPERIMENTAL","Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma",[13],"Procedure: Cryopreserved Ovarian Tissue Reimplantation",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":19},"PROCEDURE","Cryopreserved Ovarian Tissue Reimplantation",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Diego Raimondo, MD","IRCCS AOU Bologna","STUDY_CHAIR",[26],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","0512143732","die.raimondo@gmail.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Diego Raimondo","RECRUITING","Bologna","BO","40138","Italy",{"type":39,"coordinates":40},"Point",[41,42],11.33875,44.49381,{"lat":42,"lon":41},[45,48,51,53,55],{"name":22,"role":27,"phone":46,"phoneExt":47,"email":29},"0512144389","0039",{"name":49,"role":50,"phone":19,"phoneExt":19,"email":19},"Renato Seracchioli, MD","PRINCIPAL_INVESTIGATOR",{"name":22,"role":52,"phone":19,"phoneExt":19,"email":19},"SUB_INVESTIGATOR",{"name":54,"role":52,"phone":19,"phoneExt":19,"email":19},"Rossella Vicenti, PhD",{"name":56,"role":52,"phone":19,"phoneExt":19,"email":19},"Valentina Magnani, PhD",{"type":50,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Renato Seracchioli","Professor","100536194",false,"NCT06261658","Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma","TESOVA2022","Inclusion Criteria:\n\n* request for cryopreserved ovarian tissue transplantation;\n* premature ovarian failure or irregular mentrual cycles;\n* negative test for HIV, HBV, HCV, Treponema pallidum;\n* negative PAP test;\n* oncological authorization;\n* absence of neoplastic contamination in the cryopreserved ovarian tissue;\n* Informed consent\n\nExclusion Criteria:\n\n* neoplastic contamination in cryopreserved ovarian tissue;\n* history of endometriosis;\n* endocrinological disorders present and not treated (uncompensated thyroid dysfunction, diabetes (type 1, type 2);\n* body mass index (BMI) \\>30 kg\u002Fm2;\n* circulating platelet level \\\u003C 150,000 \u002F mml;\n* bacterial infection;\n* ongoing use of anticoagulants;\n* bleeding diathesis.","FEMALE",{"count":68,"type":69},45,"ESTIMATED","INTERVENTIONAL",[72],"NA","The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.",[75,76,77,78],"Cryopreservation","Ovary Injury","Infertility, Female","Menopause Ovarian Failure",[80,81,82,83,84],"Cryopreserved Ovarian Tissue","Ovarian tissue transplantation","Platelet-enriched Autologous Plasma","ovarian endocrine function","livebirths","2024-02-08",{"date":87,"type":88},"2024-02-15","ACTUAL",{"date":90,"type":69},"2024-03-01",{"date":92,"type":69},"2033-12-29",{"name":5,"class":6},1]